CIAM
NRXP icon

Caitong International Asset Management’s NRX Pharmaceuticals NRXP Stock Holding History

Caitong International Asset Management’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$274 Buy
+67
New +$221 ﹤0.01% 1920

Other funds holding NRXP

Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
OWMIAS
One Wealth Management Investment & Advisory Services Miami Beach, Florida $95.3M AUM 25.31% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return

Caitong International Asset Management's NRXP Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in NRX Pharmaceuticals (NRXP) in Q2 2026: 67 shares worth $274. The stake represents ﹤0.01% of the portfolio and ranks #1920 among its holdings.

9 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.

  • Caitong International Asset Management held 67 shares of NRX Pharmaceuticals worth $274 as of Q2 2026.
  • NRX Pharmaceuticals was a new Caitong International Asset Management position in Q2 2026.
  • NRX Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1920 holding.
  • 9 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.